All In Biotech

Drug Trial Radar · NCT07010263

A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy

A Multicenter, Randomized, Double-blind, Phase III Clinical Study of Comparing the Efficacy and Safety of AK112 (PD-1/VEGF Bispecific Antibody) Versus Placebo as Consolidation Treatment for Patients With Limited Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Last checked: Nov 19, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 560 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

560

Planned (sponsor's estimate)

Start

Jun 13, 2025

Primary completion

Dec 31, 2028

Study completion Jul 31, 2029

Sponsor

Lead sponsor
AkesoIndustry
Sponsor type
Industry
First posted
Jun 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, phase III clinical study to compare the efficacy and safety of AK112 to placebo as consolidation treatment for patients with limited stage small cell lung cancer who have not progressed following concurrent chemoradiation therapy.

Conditions

  • Small Cell Lung Cancer

Interventions

  • AK112Drug

    AK112 20mg/kg, intravenous \[IV\]),Q3W

  • PlaceboOther

    Placebo, intravenous \[IV\]),Q3W

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival(PFS) assessed by Blinded independent center review(BIRC)Time frame: Approximately 6 years
  2. Overall Survival (OS)Time frame: Approximately 6 years

Locations

53 sites in 1 country. Site status is shown where the registry gives one.

  • Cancer Hospital, Chinese Academy of Medical Sciences

    Beijin, Beijin, China · Recruiting

  • Beijing Cancer Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The First Medical Center of Chinese PLA General Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Beijing Chest Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Beijing Luhe Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Recruiting

  • Fujian Cancer Hospital

    Fuzhou, Fujian, China · Recruiting

  • PLA No. 900 Hospital of the Joint Support Force

    Fuzhou, Fujian, China · Recruiting

  • Longyan First Hospital

    Longyan, Fujian, China · Recruiting

  • Zhangzhou Municipal Hospital of Fujian Province

    Zhangzhou, Fujian, China · Recruiting

  • Gansu Provincial Cancer Hospital

    Lanzhou, Gansu, China · Recruiting

  • Jiangmen Central Hospital

    Jiangmen, Guangdong, China · Recruiting

  • Liuzhou People's Hospital

    Liuzhou, Guangxi, China · Recruiting

  • Affiliated Cancer Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Recruiting

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangzhou, China · Recruiting

  • Guizhou Provincial People's Hospital

    Guiyang, Guizhou, China · Recruiting

  • The Second Affiliated Hospital of Zunyi Medical University

    Zunyi, Guizhou, China · Recruiting

  • The Fourth Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Recruiting

  • Tangshan People's Hospital

    Tangshan, Hebei, China · Recruiting

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, China · Recruiting

  • The Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, China · Recruiting

  • Anyang Cancer Hospital

    Anyang, Henan, China · Recruiting

  • The First Affiliated Hospital of Xinxiang Medical University

    Xinxiang, Henan, China · Recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, China · Recruiting

  • Jingzhou First People's Hospital

    Jingzhou, Hubei, China · Recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Not yet recruiting

  • Hunan Cancer Hospital

    Changsha, Hunan, China · Recruiting

  • Hunan Cancer Hospital

    Changsha, Hunan, China · Recruiting

  • The First Affiliated Hospital of South China University

    Hengyang, Hunan, China · Recruiting

  • General Hospital of the PLA Eastern Theater Command

    Nanjing, Jiangsu, China · Recruiting

  • Jiangsu Cancer Hospital

    Nanjing, Jiangsu, China · Recruiting

  • Xuzhou Municipal Hospital

    Xuzhou, Jiangsu, China · Recruiting

  • The First Affiliated Hospital of Gannan Medical University

    Gannan, Jiangxi, China · Recruiting

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China · Recruiting

  • Jilin Cancer Hospital

    Changchun, Jilin, China · Recruiting

  • The First Hospital of China Medical University

    Shenyang, Liaoning, China · Recruiting

  • Ningxia Medical University General Hospital

    Yinchuan, Ningxia, China · Recruiting

  • Shandong Provincial Hospital

    Jinan, Shandong, China · Recruiting

  • Shandong Cancer Hospital

    Jinan, Shandong, China · Recruiting

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.